These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25960210)

  • 1. Development of thalidomide-loaded biodegradable devices and evaluation of the effect on inhibition of inflammation and angiogenesis after subcutaneous application.
    Pereira BG; Batista LF; de Souza PA; da Silva GR; Andrade SP; Serakides R; da Nova Mussel W; Silva-Cunha A; Fialho SL
    Biomed Pharmacother; 2015 Apr; 71():21-8. PubMed ID: 25960210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effects of thalidomide-loaded biodegradable devices in solid Ehrlich tumor.
    Pereira BG; Ligorio Fialho S; Maria de Souza C; Dantas Cassali G; Silva-Cunha A
    Biomed Pharmacother; 2013 Mar; 67(2):129-32. PubMed ID: 23089474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-articular leflunomide-loaded poly(ε-caprolactone) implants to treat synovitis in rheumatoid arthritis.
    Gomes TF; Gualberto FCM; Perasoli FB; Andrade FP; Moura SAL; Da Silva GR
    Pharmazie; 2019 Apr; 74(4):212-220. PubMed ID: 30940304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local drug delivery system: inhibition of inflammatory angiogenesis in a murine sponge model by dexamethasone-loaded polyurethane implants.
    Moura SA; Lima LD; Andrade SP; Da Silva-Cunha A; Órefice RL; Ayres E; Da Silva GR
    J Pharm Sci; 2011 Jul; 100(7):2886-95. PubMed ID: 21283986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo release and retinal safety of intravitreal implants of thalidomide in rabbit eyes and antiangiogenic effect on the chorioallantoic membrane.
    Fialho SL; Souza PA; Fulgêncio GO; Miranda MM; Pereira BG; Haddad A; Messias A; Jorge R; Silva-Cunha A
    J Drug Target; 2013 Nov; 21(9):837-45. PubMed ID: 23952807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic background determines mouse strain differences in inflammatory angiogenesis.
    Marques SM; Campos PP; Castro PR; Cardoso CC; Ferreira MA; Andrade SP
    Microvasc Res; 2011 Nov; 82(3):246-52. PubMed ID: 21907724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanosoma cruzi antigens induce inflammatory angiogenesis in a mouse subcutaneous sponge model.
    Guedes-da-Silva FH; Shrestha D; Salles BC; Figueiredo VP; Lopes LR; Dias L; Barcelos Lda S; Moura S; de Andrade SP; Talvani A
    Microvasc Res; 2015 Jan; 97():130-6. PubMed ID: 25446369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiopreventive versus angiopromoting effects of allopurinol in the murine sponge model.
    Orellano LA; Almeida SA; Campos PP; Andrade SP
    Microvasc Res; 2015 Sep; 101():118-26. PubMed ID: 26215931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The angiogenic effect of ONO-1301, a novel long-acting prostacyclin agonist loaded in PLGA microspheres prepared using different molecular weights of PLGA, in a murine sponge model.
    Hazekawa M; Morihata K; Yoshida M; Sakai Y; Uchida T
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1435-42. PubMed ID: 23937583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide attenuates mammary cancer associated-inflammation, angiogenesis and tumor growth in mice.
    Maria de Souza C; Fonseca de Carvalho L; da Silva Vieira T; Cândida Araújo E Silva A; Teresa Paz Lopes M; Alves Neves Diniz Ferreira M; Passos Andrade S; Dantas Cassali G
    Biomed Pharmacother; 2012 Oct; 66(7):491-8. PubMed ID: 22705333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate Locally Released from Poly(e-Caprolactone) Implants: Inhibition of the Inflammatory Angiogenesis Response in a Murine Sponge Model and the Absence of Systemic Toxicity.
    De Oliveira LG; Figueiredo LA; Fernandes-Cunha GM; Marina Barcelos de M; Machado LA; Dasilva GR; Sandra Aparecida Lima de M
    J Pharm Sci; 2015 Nov; 104(11):3731-42. PubMed ID: 27524686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and evaluation of a novel biodegradable long-acting intravitreal implant containing ligustrazine for the treatment of proliferative vitreoretinopathy.
    Zhang X; Wei J; Ma P; Mu H; Wang A; Zhang L; Wu Z; Sun K
    J Pharm Pharmacol; 2015 Feb; 67(2):160-9. PubMed ID: 25557298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of rolipram on chronic subcutaneous inflammatory angiogenesis and on peritoneal adhesion in mice.
    Mendes JB; Rocha MA; Araújo FA; Moura SA; Ferreira MA; Andrade SP
    Microvasc Res; 2009 Dec; 78(3):265-71. PubMed ID: 19732781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foreign body response to subcutaneous biomaterial implants in a mast cell-deficient Kit(w-Sh) murine model.
    Avula MN; Rao AN; McGill LD; Grainger DW; Solzbacher F
    Acta Biomater; 2014 May; 10(5):1856-63. PubMed ID: 24406200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
    Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
    J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo evaluation of a novel electrically conductive polypyrrole/poly(D,L-lactide) composite and polypyrrole-coated poly(D,L-lactide-co-glycolide) membranes.
    Wang Z; Roberge C; Dao LH; Wan Y; Shi G; Rouabhia M; Guidoin R; Zhang Z
    J Biomed Mater Res A; 2004 Jul; 70(1):28-38. PubMed ID: 15174106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel hemostatic delivery device for thrombin: biodegradable poly(D,L-lactide-co-glycolide) 50:50 microspheres.
    Smeets R; Gerhards F; Stein JM; Paz RM; Vogt S; Pautke C; Weitz J; Kolk A
    J Biomed Mater Res A; 2011 Jan; 96(1):177-85. PubMed ID: 21105166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits.
    Yasukawa T; Kimura H; Tabata Y; Miyamoto H; Honda Y; Ogura Y
    Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):672-8. PubMed ID: 12192462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
    Derakhshandeh K; Erfan M; Dadashzadeh S
    Eur J Pharm Biopharm; 2007 Apr; 66(1):34-41. PubMed ID: 17070678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone.
    da Silva AA; de Matos JR; Formariz TP; Rossanezi G; Scarpa MV; do Egito ES; de Oliveira AG
    Int J Pharm; 2009 Feb; 368(1-2):45-55. PubMed ID: 18992313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.